MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, LCTX has $109,533K in assets. $56,838K in debts. $35,939K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
689.30%
Quick Ratio
689.30%
Cash Ratio
441.08%
Debt to Asset Ratio
51.89%
Unit: Thousand (K) dollars
Assets Breakdown
    • Included within cash and cash eq...
    • Intangible assets, net
    • Goodwill
    • Others
Liabilities Breakdown
    • Common shares, no par value, 450...
    • Accumulated deficit
    • Warrant liabilities
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Included within cash and cash equivalents
35,939 40,791 40,463 42,271
Marketable securities
17,442 14,990 23 17
Accounts receivable
806 891 127 256
Prepaid expenses and other current assets
1,977 2,485 1,647 1,300
Total current assets
56,164 59,157 42,260 43,844
Property and equipment, net
2,497 2,566 2,157 2,255
Operating lease right-of-use assets
2,127 2,131 2,311 1,817
Deposits and other long-term assets
573 558 539 511
Goodwill
10,672 10,672 10,672 10,672
Intangible assets, net
31,700 31,700 31,700 31,700
Deferred tax asset, net
5,800 5,800 --
Total assets
109,533 112,584 89,639 90,799
Accounts payable and accrued liabilities
5,567 7,181 4,550 4,451
Operating lease liabilities, current portion
833 816 1,023 998
Finance lease liabilities, current portion
32 37 43 50
Deferred revenues, current portion
1,716 3,333 3,766 5,257
Total current liabilities
8,148 11,367 9,382 10,756
Deferred tax liability, net
22 22 273 273
Deferred revenues, net of current portion
12,999 12,377 12,462 12,751
Operating lease liabilities, net of current portion
1,507 1,534 1,515 1,058
Finance lease liabilities, net of current portion
22 32 40 48
Warrant liabilities
34,140 43,906 45,171 18,801
Preferred shares, no par value, 2,000 shares authorized none issued and outstanding as of june 30, 2025 and december 31, 2024
---0
Total liabilities
56,838 69,238 68,843 43,687
Common shares, no par value, 450,000 shares authorized as of march 31, 2026 and december 31, 2025 249,298 and 243,122 shares issued and outstanding as of march 31, 2026 and december 31, 2025 , respectively
529,656 515,467 494,175 490,551
Accumulated other comprehensive loss
-3,971 -3,920 -4,286 -4,098
Accumulated deficit
-471,810 -466,998 -467,849 -438,068
Lineage's shareholders' equity
53,875 44,549 22,040 48,385
Noncontrolling deficit
-1,180 -1,203 -1,244 -1,273
Total shareholders equity
52,695 43,346 20,796 47,112
Total liabilities and shareholders equity
109,533 112,584 89,639 90,799
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Included within cash andcash equivalents$35,939K Marketable securities$17,442K Prepaid expenses andother current assets$1,977K Accounts receivable$806K Total current assets$56,164K Intangible assets, net$31,700K Goodwill$10,672K Deferred tax asset, net$5,800K Property and equipment,net$2,497K Operating leaseright-of-use assets$2,127K Deposits and otherlong-term assets$573K Total assets$109,533K Total liabilities andshareholders equity$109,533K Total liabilities$56,838K Total shareholdersequity$52,695K Noncontrolling deficit-$1,180K Warrant liabilities$34,140K Deferred revenues, net ofcurrent portion$12,999K Total currentliabilities$8,148K Operating leaseliabilities, net of current...$1,507K Finance leaseliabilities, net of current...$22K Deferred tax liability,net$22K Lineage's shareholders'equity$53,875K Accumulated deficit-$471,810K Accumulated othercomprehensive loss-$3,971K Accounts payable andaccrued liabilities$5,567K Deferred revenues,current portion$1,716K Operating leaseliabilities, current portion$833K Finance leaseliabilities, current portion$32K Common shares, no parvalue, 450,000 shares...$529,656K

Lineage Cell Therapeutics, Inc. (LCTX)

Lineage Cell Therapeutics, Inc. (LCTX)